Search results
Maryland's retirees fear mounting healthcare costs due to prescription drug plan changes
WBFF Fox45 Baltimore· 1 day agoBack in January, thousands of retired state workers received a letter from Maryland’s Department of...
Q1 2024 Blueprint Medicines Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 8 minutes agoImportantly, unlike last year, we expect these patients will be able to stay on therapy for the rest of the year due to changes to the out-of-pocket cap as part of Medicare
What is the Medicare Donut Hole and What Are Your Options?
Penny Hoarder via AOL· 5 days agoMedicare can feel complicated. It’s easy to get overwhelmed when sorting through pages of...
A ‘slap in the face’: Retired state workers in Maryland outraged by drug plan switch
Baltimore Sun· 2 days agoBefore receiving a heart transplant in 2020, Mark Varner avoided imagining his life too far into the...
Does Medicare pay for hearing aids?
CBS News· 6 days agoFor those who live with mild to severe hearing loss, shopping for good quality hearing aids can be a headache. If you're over 65, you may be wondering if...
Savvy Senior: Recommended vaccines for Medicare recipients
Daily Press· 7 days agoMy husband and I recently turned 65 and would like to find out which vaccines are recommended and...
Pfizer stock gains 7% after earnings beat, company calls dividend 'secure'
Yahoo Finance· 1 day agoEliquis represents nearly 14% of Pfizer’s Q1 revenue, and we recognize the uncertainty tied to the...
CMS Advises Preparatory Steps for Anticipated PrEP Coverage Transition to Medicare Part B | JD Supra
JD Supra· 7 days agoCMS did not announce any coverage changes in the fact sheet but is providing advance information to avoid any possible disruptions to beneficiaries should the NCD be issued. Under the proposed ...
Collegium (COLL) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 3 days agoCOLL renegotiated a major Medicare Part D contract for Belbuca, maintaining its access position and...
Exelixis Inc (EXEL) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
GuruFocus.com via Yahoo Finance· 2 days agoCABOMETYX Net Product Revenues: $376.4 million, including about $6 million in clinical trial sales. Gross to Net Deductions: 32.9% for Q1 2024, primarily due to higher Medicare</ ...
